Cytochrome P450 1A2 (CYP1A2) Genotyping
Idiopathic Pulmonary Fibrosis Diagnostic Test (Envisia™)
Fractional excretion of sodium
Friedreich Ataxia, Frataxin, Quantitative, Blood
HLA Class II Typing, Antigen or Genotyping
Lipoprotein Electrophoresis
Prostaglandin D2 (PGD2), Serum
Bruton Tyrosine Kinase (BTK) Gene Mutation Analysis
G6PC (Glucose-6-phosphatase, Catalytic Subunit), Glycogen Storage Disease Type 1 (von Gierke Disease) Gene Mutation Analysis
Epstein-Barr Virus (EBV) VCA, IgM
LDS
Sign up
Log in
LDS
/
Medical Tests
/
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
Medical Test
References
Access to
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
is restricted.
Sign up now